Study to Assess the Efficacy, Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latanoprost in Patients With Ocular Hypertension or Open Angle Glaucoma
Clinical trial NCT04405245 · COMPLETED
Trial details
- NCT number
- NCT04405245
- Sponsor
- EyePoint Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-06
- Primary completion
- 2020-11-05
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.